BP000027-GD1: Recombinant Human VEGF165 (aa 27-191) Protein
Source: HEK 293 cell-derived.
The VEGF activity is measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC). The ED50 for this effect is typically 1-5 ng/ml.
Endotoxin: < 1.0 EU per ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions.BP000027-C083: Recombinant Human Vascular Endothelial Growth Factor Isoform 165 (VEGF165) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000027-CYT-116: Recombinant Human VEGF (121 a.a) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of HUVEC cells (Human Umbilical Vein Endothelial Cells) and is typically 2-8 ng/ml.
Purity: > 95% by SDS-PAGE.BP000027-CYT-343: Recombinant Human Vascular Endothelial Growth Factor (121 a.a) Protein
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 0.2-0.4 ng/ml corresponding to a specific activity of 2.5-5 MU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000027-CYT-392: Recombinant Rat Vascular Endothelial Growth Factor (VEGF) Protein
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 4.0-8.0 ng/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.BP000027-CYT-496: Recombinant Human Vascular Endothelial Growth Factor (VEGF) Protein, His Tag
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000027-CYT-574: Recombinant Mouse VEGF (121 a.a) Protein
Source: E. coli-derived.
Purity: > 97% by SDS-PAGE and RP-HPLC.